Use of estrogen in treatment of familial hemorrhagic telangiectasia
Open Access
- 1 March 1982
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 92 (3) , 314-320
- https://doi.org/10.1288/00005537-198203000-00017
Abstract
Within a 25 year period, 118 patients with a definitive diagnosis of familial hemorrhagic telangiectasia were treated for recurrent epistaxis. Twenty‐eight patients had dermoplasty but 67 patients received large dose estrogen therapy using ethinyl estradiol. The latter regime proved successful in every patient and the side effects and possible disadvantages of this treatment are considered in detail.Keywords
This publication has 9 references indexed in Scilit:
- Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia: Review of 80 CasesJAMA Otolaryngology–Head & Neck Surgery, 1977
- Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Disease) Management of Epistaxis in Nine Patients Using Systemic Hormone TherapyJAMA Otolaryngology–Head & Neck Surgery, 1977
- Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Disease) An Electron Microscopic Study of the Vascular Lesions Before and After Therapy With HormonesJAMA Otolaryngology–Head & Neck Surgery, 1975
- MANAGEMENT OF EPISTAXIS IN OSLERWEBER-RENDU DISEASEPlastic and Reconstructive Surgery, 1972
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970
- Ultrastructure ofJAMA Otolaryngology–Head & Neck Surgery, 1970
- Hereditary Hemorrhagic Telangiectasia: Review of 102 Cases and Presentation of an Innovation to SeptodermoplastyJAMA Otolaryngology–Head & Neck Surgery, 1965
- Long-term Treatment of Epistaxis with OestrogensBMJ, 1963
- HORMONAL MANAGEMENT OF HEREDITARY HEMORRHAGIC TELANGIECTASIAJAMA, 1952